Ciprofloxacin 1986
DOI: 10.1007/978-3-663-01930-5_3
|View full text |Cite
|
Sign up to set email alerts
|

The In Vitro and In Vivo Activity of Ciprofloxacin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
11
0

Year Published

1990
1990
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 5 publications
1
11
0
Order By: Relevance
“…Ciprofloxacin is an antibiotic used for the treatment of bacterial infections, belonging to the fluoroquinolones class . The mode of action of this drug encompasses the inhibition of prokaryotic DNA gyrase, but its influence on vertebrate DNA enzymes is several orders of magnitude weaker .…”
Section: Introductionsupporting
confidence: 78%
“…Ciprofloxacin is an antibiotic used for the treatment of bacterial infections, belonging to the fluoroquinolones class . The mode of action of this drug encompasses the inhibition of prokaryotic DNA gyrase, but its influence on vertebrate DNA enzymes is several orders of magnitude weaker .…”
Section: Introductionsupporting
confidence: 78%
“…In Costa Rica the high resistance rates found can be explained based on an indiscriminate and frequent use of common antibiotics such as amoxycillin and first and second generation cephalosporines, the non-efficient control practices of hospitalary infections and a limited medicinal vigilance by health authorities. At the same time, the low resistance rates to agents such as imipenem and ciprofloxacine can be explained by in its low consumption and later appearance in the market (22). The resistance rates obtained by the Kirby-Bauer method and ATB antibiogram show no statistical difference between the techniques, the slight differences between both are due to the fact that ATB antibiogram generally uses antibiotics in pairs.…”
Section: Discussionmentioning
confidence: 96%
“…It is also affected by the state of host defences (Bodey, Feld & Burgess, 1976) and environmental factors present at the infection site (Bryant & Hammond, 1974;Zeiler, 1985). Experimental local or systemic infection models are often used to evaluate the potential in-vivo efficacy of antimicrobial agents (Zeiler & Grohe, 1984;Heifetz et al, 1988). Although there are some disadvantages and variability inherent in these screening models (Barza, 1978), their predictive ability has, generally, been good (Miraglia, 1976;Bergeron, 1978).…”
Section: Discussionmentioning
confidence: 99%